1.An Immunohistochemical Study of the Relationships between Estrogen and Progesterone Receptors and Proliferating Cell Nuclear Antigen in Endometrial Hyperplasia and Adenocarcinoma.
Seol Mi PARK ; Hye Kyoung YOON ; Jong Eun JOO
Korean Journal of Pathology 1996;30(1):15-22
Estrogen and progesterone receptors exist in the epithelial and stromal cells of the endometrium. Proliferative disorders of the endometrium may be associated with autocrine and paracrine actions of estrogen and progesterone in epithelial and stromal cells. This study was performed to evaluate the differences estrogen and progesterone receptor(ER/PR) expression in the epithelial and stromal cells of endometrial hyperplasias and adenocarcinomas using immunohistochemical methods. Immunohistochemical analysis of proliferating cell nuclear antigen(PCNA) was done to evaluate a possible correlation between PCNA and hormone receptor expression. Evaluation was based on samples from 31 simple hyperplasias, 30 complex hyperplasias, and 32 adenocarcinomas. The immunohistochemical expression of ER, PR and PCNA in epithelial and stromal cells were examined according to a scoring system based on the percentage of positive cells and the staining intensity. The results were as follows; 1) The expression of ER and PR in epithelial cells showed a graded, significant decreases in simple hyperplasia, complex hyperplasia and endometrial carcinoma, in that order(ER: P=0.008, PR: P= 0.026). 2) PR expression in the stromal cells showed a significant decrease between hyperplasia and adenocarcinoma(P=0.003). The difference in ER expression was not significant. 3) In stromal cells, the decrease in PR expression was more prominent than the decrease in ER expression when complex hyperplasia was compared to simple hyperplasia. 4) The PCNA expression in simple and complex hyperplasia and adenocarcinoma was not higher than the expression of PCNA in nomal proliferative endometrium. There was no significant difference in PCNA expression between simple and complex hyperplasia and adenocarcinoma(P=0.073). 5) A negative correlation between PCNA and ER/PR expression was not demonstrated in simple and complex hyperplasia, or in adenocarcinoma. Endometrial hyperplasia and adenocarcinoma are probably related to a paracrine action of estrogen and progesterone in epithelial and stromal cells. A progressive loss of PR expression in stromal cells may induce abnormal proliferation of endometrium due to a disrupted hormonal balance.
Adenocarcinoma
2.Disseminated intravascular coagulation(DIC) associated with gastric adenocarcinoma.
Soon Koo BAIK ; Heon Soo KIM ; Jong In LEE ; Woo Ick JANG ; Young Hak SHIM
Journal of the Korean Cancer Association 1992;24(3):456-462
No abstract available.
Adenocarcinoma*
3.The Outcomes of 17,744 Cervicovaginal Smears in Ihha University Hospital.
Eun Seop SONG ; Sang Hoon HAN ; Jee Hyun PARK ; Kwoan Young OH ; Young Koo LIM ; Moon Whan IM ; Byoung Ick LEE ; Jee Young HAN ; Jong Hwa KIM
Korean Journal of Obstetrics and Gynecology 2000;43(3):363-367
OBJECTIVE: Our purpose was to investigate the distribution of the result of 17,744 cervicovaginal smears and their pathologic results in Inha University Hospital to make a reference data. METHODS: During 28 months, May 1996 to August 1998, we performed 17,774 cervicovaginal smears and arranged them by the Bethesda system and compared them with their pathologic results. RESULTS: Among 17,744 smears, there were 93.2% of benign results, 2.9% of ASCUS, 0.9% of LSIL, 1.4% of HSIL, and 0.8% of SCC. The ASCUS/SIL ratio was 1.28. Among ASCUS, the high grade histologic outcome was composed 4.0%. Among LSIL, there were 15.7%, and HSIL 48.0%, SCC 56.1%, AGUS 9.3%, and Adenocarcinoma, the results was 69.2%. CONCLUSION: Among 17,744 smears, there were 93.2% of benign results, 2.9% of ASCUS, 0.9% of LSIL, 1.4% of HSIL, and 0.8% of SCC. The ASCUS/SIL ratio was 1.28. These results were very similar to other data and we would like to add our data to them as a reference. And the worse the smear results were, the worse the pathologic results were.
Adenocarcinoma
4.Mucinous Adenocarcinoma of Anal Ducts.
Young Ha OH ; Wan Seop KIM ; Eun Kyung HONG ; Moon Hyang PARK ; Jung Dal LEE
Korean Journal of Pathology 1996;30(9):843-850
Anal duct carcinoma is a rare tumor, and accounts for less than 5 percent of all anal cancers, which typically present a long-standing perianal fistulas. Some authors suggest that the fistulous tracts are congenital duplications of the lower end of the hind gut lined by rectal mucosa which is prone to malignant change to mucinous adenocarcinoma. It is usually a well differentiated mucinous (colloid) adenocarcinoma. The prognosis after wide excision of the rectum is relatively good. Since 1985, we have had three cases of anal duct carcinoma with well differentiated mucinous adenocarcinoma involving the posterior wall of the anus. Two patients had a long history of perianal fistula with mucinous discharge. There was no spread to the regional lymph node except one patient who had regional lymph node metastasis, and post-operative chemotherapy and radiation therapy were then given. All patients have no evidence of any recurrent problem at 16 months to 3 years following the surgical treatment. Because of their rarity and the failure of recognition at an early stage, we are presenting three cases to emphasize the characteristic features of this insidious, slow-growing carcinoma.
Adenocarcinoma
5.Goblet Cell Carcinoid of the Appendix: A case report.
Joo Heon KIM ; Ho LEE ; So Young OH ; Myoung Jae KANG ; Ho Yeul CHOI ; Dong Geun LEE
Korean Journal of Pathology 1996;30(9):839-842
Carcinoid tumors of the appendix are common incidental findings, but appendiceal tumors with histologic features of both carcinoids and adenocarcinomas are rare, and their biologic behavior and histogenesis are still unclear. We report a case of goblet cell carcinoid of the appendix in a 54-year-old male, who exhibited pain in the right lower abdomen. Microscopically, the tumor contained smooth-bordered, widely separated nests composed of tumor cells with abundant mucin. The principal tumor cell type had a close resemblance to the normal goblet cell. Histochemically, the tumor cells revealed positive reaction for PAS and alcian blue stain. Immunohistochemically, the tumor showed strong reactivity for carcinoembryonic antigen, chromogranin and, neuron specific enolase but none for cytokeratin and epithelial membrane antigen.
Adenocarcinoma
6.Primary appendiceal adenocarcinoma.
Jae Sub PARK ; Sung Hoon NOH ; Jin Sik MIN
Journal of the Korean Surgical Society 1991;41(4):496-502
No abstract available.
Adenocarcinoma*
7.An immunohistochemical study of CEA between endocervical and endometrial adenocarcinoma.
Young Sook HA ; Hyun Chan KIM ; Kang Suk SEO
Korean Journal of Obstetrics and Gynecology 1992;35(1):77-84
No abstract available.
Adenocarcinoma*
8.A case of Tumoral 'Pneumonia' Caused by Prostatic Adenocarcinoma.
Ki Hyun SEO ; Hyen Gyu HWANG ; Seung Chul PARK ; Kwan Seok PARK ; Seung Hyug MOON ; Yong Hoon KIM
Tuberculosis and Respiratory Diseases 1999;46(2):281-284
No abstract available.
Adenocarcinoma*
9.Birefringent Particles as an Effective Factor in Usual Interstitial Pneumonia.
Min Jung KIM ; Seung Yeon HA ; Sung Hwan JEONG ; Bongkyung SHIN
Korean Journal of Pathology 2008;42(4):198-201
BACKGROUND: It has long been recognized that birefringent paticles (BP) are associated with pulmonary disease. And there is increasing evidence that BP cause fibrotic reaction within the lung depending on both particle size and composition. METHODS: We collected 41 cases of usual interstitial pneumonia (UIP) and 101 cases of normal lung tissue from control group including squamous cell carcinoma, adenocarcinoma and bullae. BPs in the 0.1 to 10 micrometer size range under polarizing microscope was measured and counted by image analyzer. RESULTS: BP counts are mean 244.05/10 HPF in UIP and 71.4/10 HPF in control group. BPs in UIP is three times more than control (p=0.000). It increased significantly by the age of patients (p=0.000). CONCLUSIONS: BPs in lung might be important cause of inflammation and fibrosis in UIP.
Adenocarcinoma
10.Malignant Gastric Tumors Excluding Adenocarcinoma.
Byung Jo BAE ; Ki Ho PARK ; Soo Sang SOHN ; Sun Kyo SONG ; Wansik YU
Journal of the Korean Cancer Association 1997;29(2):340-343
No abstract available
Adenocarcinoma*